1 Min Read
Dec 29 (Reuters) - Galena Biopharma Inc:
* GALENA BIOPHARMA, INC. STOCKHOLDERS APPROVE BUSINESS COMBINATION WITH SELLAS LIFE SCIENCES GROUP, LTD; BOARD SETS REVERSE STOCK SPLIT RATIO Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.